With some of the most knowledgeable experts in the industry, Precision can help you keep current with information on the latest healthcare access technologies, strategies, and regulatory changes. Some of our recent leadership insight includes:
- Pull-through Breakthrough: How Your Peers Are Driving Double-Digit Gains
Led by Precision Promotional Effectiveness thought leaders Bruce Leavitt, executive vice president and managing partner, and Ashwin Athri, senior vice president, this webinar features real-world case studies guiding participants through planning and executing more impactful pull-through campaigns. While revealing key elements of an effective pull-through plan, Bruce and Ashwin also share a recent breakthrough in pull-through technology that maximizes underutilized data most pharma companies already possess. Attendees will be presented with specific case studies that drove stunning gains in access of over 14% in just 90 days, understand how to extract key messages for HCPs from existing data, and receive tips for increasing the performance and motivation of a field force.
To view the webinar, please click here to register and view on-demand.
—
- Navigating the FDA’s Final Guidance on HCEI and PIE: Value Communication That Works
This webinar shares the unique perspectives of Precision for Value’s Ross Maclean, MD, PhD, senior vice president, head of Medical Affairs, and Ami Gopalan, PharmD, MBA, vice president, director, Payer Access Solutions, on this Final Guidance. They discuss practical considerations for manufacturers in developing and disseminating health care economic information (HCEI) and pre-approval information exchange (PIE), leveraging the use of clinical, economic, and humanistic evidence to inform value assessment activities. Improving transparency and believability with reimbursement decision makers to optimize market access is a central focus.
To view the webinar, please click here to register and view on-demand.
—
- Defend Your Value: Syncing Evidence and Access Strategies to Prepare for US Value Assessments (White Paper)
With a focus on responding to the dramatic rise in US value assessment activity, Precision thought leaders Larry Blandford, PharmD, and Ross Maclean, MD, share methods to enhance the use not only of clinical, but of economic and humanistic evidence to inform external value assessment activities. The goal, they write, is to improve transparency and believability with reimbursement decision makers to optimize market access. This white paper also addresses preparing for an assessment by ICER or other third parties, assessing evidence gaps and subsequent evidence generation in building a value assessment, and combining economic evidence activities with pricing and market access work to enhance value development throughout the entire value assessment process.
To obtain a free copy, please click here to register and download.